Clinical Trial Update: Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating weekly intravenous topotecan and cisplatin with radiation for cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Topotecan (topotecan)

Snippet

Sponsor: University of California, Irvine | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED